IgE receptor alpha-IgG1 Fc(Kissei Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIgE receptor alpha-IgG1 Fc(Kissei Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionIgE receptors antagonists
TargetsIgE receptors
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKissei Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsConjunctivitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A